Skip to main content
. 2014 May 30;9(6):834–842. doi: 10.1097/JTO.0000000000000185

FIGURE 3.

FIGURE 3.

The association between primary tumor SUVmax and OS and LC of NSCLC treated by SBRT. A, The pooled HR estimate for OS of pre-SBRT primary tumor SUVmax; B, The pooled HR estimate for LC of pre-SBRT primary tumor SUVmax; C, The pooled HR estimate for LC of post-SBRT primary tumor SUVmax.

HHS Vulnerability Disclosure